Brain Function and Perfusion in Patients With Heart Failure (BRAIN-HF)
This study is currently recruiting participants.
Verified December 2012 by University Medical Centre Groningen
Sponsor:
University Medical Centre Groningen
Information provided by (Responsible Party):
A.A.Voors, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01756014
First received: December 19, 2012
Last updated: December 21, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators will evaluate the determinants of cerebral impairment in patients with non-ischemic heart failure compared to controls, and its relation to cognitive function. They hypothesize that patients with heart failure have impaired brain perfusion and hemodynamic factors are associated with cognitive dysfunction.
| Condition |
|---|
|
Heart Failure Dilated Cardiomyopathy Perfusion Cognitive Impairment Cerebral Hypoperfusion |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Brain Function and Perfusion in Patients With Heart Failure |
Resource links provided by NLM:
Further study details as provided by University Medical Centre Groningen:
Primary Outcome Measures:
- Determinants of cerebral impairment [ Time Frame: Baseline ] [ Designated as safety issue: No ]Determinants of cerebral impairment in patients with heart failure compared to controls, where cerebral impairment is defined as decreased cognitive function and cerebral hypoperfusion
Secondary Outcome Measures:
- Prevalence of cognitive impairment [ Time Frame: Baseline ] [ Designated as safety issue: No ]Prevalence of cognitive impairment in patients with heart failure
- Relation of cognitive impairment with local perfusion [ Time Frame: Baseline ] [ Designated as safety issue: No ]Relation of cognitive impairment with perfusion of carotid artery territory and basilar artery territory
- Relation of cognitive impairment with the severity of heart failure [ Time Frame: Baseline ] [ Designated as safety issue: No ]Relation of cognitive impairment with the severity of heart failure
- Relation of cognitive impairment with cardiac output [ Time Frame: Baseline ] [ Designated as safety issue: No ]Relation of cognitive impairment with cardiac output
- Relation of cognitive impairment with the severity of congestion [ Time Frame: Baseline ] [ Designated as safety issue: No ]Relation of cognitive impairment with the severity of congestion
- Relation of cognitive impairment with the decrease in cerebral perfusion [ Time Frame: Baseline ] [ Designated as safety issue: No ]Relation of cognitive impairment with the decrease in cerebral perfusion
- The difference of cognitive domains in above relations [ Time Frame: Baseline ] [ Designated as safety issue: No ]The difference of cognitive domains in above relations
| Estimated Enrollment: | 45 |
| Study Start Date: | January 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Controls
Age matched healthy subjects
|
|
Mild DCM
Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class II
|
|
Severe DCM
Heart failure patients with dilated cardiomyopathy (DCM) with NYHA-functional class III/IV
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
- Patients with heart failure due to dilated cardiomyopathy with NYHA II or NYHA II/IV.
- Healthy patients
Criteria
Inclusion Criteria Control Group:
- Healthy subject, as assessed by clinician
- Age matched with patient group
Exclusion Criteria Control Group:
- Age < 18 years
- Carotid artery or intracranial disease, as assessed by echo-doppler (significant stenosis > 50%)
- Unable or unwilling to undergo MRI
- The presence of ferromagnetic material in or on the body, for example tattoos with ferrous ink or pacemakers or cardiac defibrillators. Also the presence of pregnancy and claustrophobia.
- History of cognitive impairment
- Unable to understand procedures
- Unable or unwilling to provide informed consent
Inclusion Criteria DCM-group:
- Heart failure due to DCM
- 15 patients with NYHA class II
- 15 patients with NYHA class III/IV
Exclusion Criteria DCM-Group:
- Age < 18 years
- History of myocardial infarction
- History of peripheral artery disease
- History of cerebrovascular disease or
- Carotid artery or intracranial disease, as assessed by echo-doppler (significant stenosis > 50%)
- History of cognitive impairment
- Unable to undergo MRI (eg pacemaker)
- Unable to understand procedures
- Unable or unwilling to provide informed consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01756014
Contacts
| Contact: Adriaan A Voors, MD/PhD | +31 50 3612355 | a.a.voors@umcg.nl |
Locations
| Netherlands | |
| University Medical Centre Groningen | Recruiting |
| Groningen, Netherlands, 9700 RB | |
| Contact: Adriaan A Voors, MD/PhD +31 50 36 12355 a.a.voors@umcg.nl | |
| Principal Investigator: Adriaan A Voors, MD/PhD | |
| Principal Investigator: Gert-Jan Luijckx, MD/PhD | |
| Sub-Investigator: Vincent M van Deursen, MD/PhD | |
Sponsors and Collaborators
University Medical Centre Groningen
More Information
No publications provided
| Responsible Party: | A.A.Voors, Prof. dr., University Medical Centre Groningen |
| ClinicalTrials.gov Identifier: | NCT01756014 History of Changes |
| Other Study ID Numbers: | BRAIN-HF |
| Study First Received: | December 19, 2012 |
| Last Updated: | December 21, 2012 |
| Health Authority: | Netherlands: Medical Ethics Review Committee (METC) Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Additional relevant MeSH terms:
|
Cardiomyopathy, Dilated Heart Failure Cognition Disorders Cardiomyopathies Cardiomegaly |
Heart Diseases Cardiovascular Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 23, 2013